dsm-firmenich Builds China Drug Master File Portfolio, Achieving Active Status for Pyridoxine Hydrochloride (Vitamin B6)

Kaiseraugst

Pyridoxine hydrochloride plays an important role in neurotransmission, with potential applications in drug products to support patients with idiopathic sideroblastic anemia and vitamin B6 deficiency states. By completing the National Medical Products Administration (NMPA) technical assessment to gain an active registration number, it is now more straightforward for customers to use dsm-firmenich’s vitamin B6 API in the development of pharmaceutical products against the backdrop of a changing regulatory environment in China. dsm-firmenich has a proven record in quality assurance, guaranteeing a reliable, sustainable supply of products to its pharmaceutical customers worldwide.

“The CDMF plays a critical role in facilitating and accelerating the approval of drug products. This fully active status ensures that our customers developing finished drug products for the Chinese market have access to a trusted partner for the supply of pyridoxine hydrochloride, produced under the high-quality standards of pharmaceutical GMP,” comments Kelsey Achenbach, Global Segment Director, Pharma and Medical Nutrition at dsm-firmenich.

dsm-firmenich currently holds CDMFs for a number of its other vitamin APIs, including ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E), and puts resources behind further building a strong CDMF portfolio. Upon request, dsm-firmenich can support its partners with additional filings. For more information on how dsm-firmenich’s end-to-end support can enable drug products to meet their full potential and benefit the health of millions of patients worldwide, visit Pharma Solutions | DSM

dsm-firmenich – Bright Science. Brighter Living.™

Royal dsm-firmenich is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. dsm-firmenich’s purpose is to create brighter lives for all. dsm-firmenich’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at dsm-firmenich - We bring progress to life.